Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells expressing CD11b and CD11c are a subset of immune cells that play a crucial role in bridging the innate and adaptive immune systems. They are involved in antigen uptake, processing, and presentation to T cells, thereby initiating immune responses. CD11c is a defining marker for dendritic cells, while CD11b is also expressed on certain subsets, contributing to their phagocytic and antigen-presenting capabilities. These cells are pivotal in inflammatory responses and can influence the development of various diseases, including cancer and autoimmune conditions.
Not applicable directly, but therapies targeting dendritic cell functions often involve modulating antigen presentation or immune activation pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cells expressing CD11b and CD11c (CD11b+CD11c+ DCs).